Notify me when EQUITY INVESTMENT CORP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 72 | $4,953,302,271 | +$478,973,970 | -$367,611,397 | +$111,362,573 | GSK, VZ, WFC, USB, UPS | 13F-HR | 11 Feb 2026, 21:14 |
| Q3 2025 | 64 | $4,773,578,774 | +$382,517,027 | -$201,931,928 | +$180,585,099 | VZ, GSK, WFC, USB, MDT | 13F-HR | 04 Nov 2025, 21:40 |
| Q2 2025 | 62 | $4,476,928,895 | +$568,788,147 | -$626,730,269 | -$57,942,122 | VZ, GSK, WFC, PYPL, USB | 13F-HR | 05 Aug 2025, 19:38 |
| Q1 2025 | 66 | $4,472,459,292 | +$376,382,439 | -$413,567,197 | -$37,184,758 | SGOV, VZ, T, GSK, TTE | 13F-HR | 02 May 2025, 13:36 |
| Q4 2024 | 63 | $4,265,826,709 | +$370,843,074 | -$335,625,800 | +$35,217,274 | T, WFC, VZ, PYPL, KVUE | 13F-HR | 04 Feb 2025, 19:21 |
| Q3 2024 | 65 | $4,298,204,571 | +$214,533,287 | -$173,094,834 | +$41,438,453 | T, VZ, SGOV, PYPL, KVUE | 13F-HR | 07 Nov 2024, 11:41 |
| Q2 2024 | 65 | $3,915,263,950 | +$212,254,743 | -$139,674,100 | +$72,580,643 | T, VZ, SGOV, WFC, GSK | 13F-HR | 07 Aug 2024, 19:31 |
| Q1 2024 | 63 | $3,997,610,302 | +$471,862,957 | -$302,433,529 | +$169,429,428 | VZ, SGOV, T, WFC, UL | 13F-HR | 06 May 2024, 21:47 |
| Q4 2023 | 60 | $3,559,968,163 | +$187,063,487 | -$209,226,257 | -$22,162,770 | VZ, T, SGOV, WFC, GSK | 13F-HR | 08 Feb 2024, 17:28 |
| Q3 2023 | 59 | $3,213,062,081 | +$243,291,826 | -$163,074,291 | +$80,217,535 | SGOV, T, GSK, VZ, TTE | 13F-HR | 07 Nov 2023, 20:29 |
| Q2 2023 | 60 | $3,231,633,403 | +$327,184,649 | -$229,280,342 | +$97,904,307 | SGOV, VZ, GSK, WFC, T | 13F-HR | 02 Aug 2023, 18:47 |
| Q1 2023 | 57 | $3,050,777,270 | +$205,568,868 | -$94,731,640 | +$110,837,228 | T, VZ, GSK, INGR, META | 13F-HR | 03 May 2023, 21:34 |
| Q4 2022 | 56 | $2,972,858,862 | +$278,817,249 | -$215,925,414 | +$62,891,835 | T, TTE, VZ, INGR, GL | 13F-HR | 07 Feb 2023, 20:47 |
| Q3 2022 | 53 | $2,607,490,000 | +$298,158,730 | -$213,060,048 | +$85,098,682 | T, GL, WFC, TTE, INGR | 13F-HR | 09 Nov 2022, 14:54 |
| Q2 2022 | 56 | $2,700,653,000 | +$309,045,770 | -$243,220,324 | +$65,825,446 | GSK, T, VZ, TTE, INGR | 13F-HR | 08 Aug 2022, 16:36 |
| Q1 2022 | 59 | $2,929,035,000 | +$536,761,255 | -$470,416,110 | +$66,345,145 | T, GSK, VZ, WMB, DLTR | 13F-HR | 10 May 2022, 15:06 |
| Q4 2021 | 54 | $2,762,578,000 | +$232,316,864 | -$256,950,852 | -$24,633,988 | GSK, DLTR, VZ, WFC, GD | 13F-HR | 07 Feb 2022, 20:14 |
| Q3 2021 | 53 | $2,608,400,000 | +$61,652,598 | -$91,245,728 | -$29,593,130 | GSK, VZ, WFC, GD, T | 13F-HR | 15 Nov 2021, 09:56 |
| Q2 2021 | 53 | $2,655,774,000 | +$216,249,462 | -$189,541,465 | +$26,707,997 | GSK, VZ, WFC, WMB, AXP | 13F-HR | 06 Aug 2021, 11:15 |
| Q1 2021 | 52 | $2,515,127,000 | +$199,883,098 | -$149,015,525 | +$50,867,573 | VZ, GSK, HIG, WFC, USB | 13F-HR | 12 May 2021, 15:12 |
| Q4 2020 | 51 | $2,143,968,000 | +$173,984,129 | -$275,202,553 | -$101,218,424 | SCHW, GSK, VZ, HIG, USB | 13F-HR | 09 Feb 2021, 21:42 |
| Q3 2020 | 52 | $1,964,730,000 | +$199,931,814 | -$309,001,330 | -$109,069,516 | UPS, VZ, JNJ, GSK, SCHW | 13F-HR | 12 Nov 2020, 17:23 |
| Q2 2020 | 50 | $2,012,869,000 | +$142,655,051 | -$344,998,551 | -$202,343,500 | VZ, UPS, GSK, TFC, TRV | 13F-HR | 10 Aug 2020, 09:43 |
| Q1 2020 | 49 | $1,938,193,000 | +$333,173,371 | -$581,235,939 | -$248,062,568 | VZ, UPS, JNJ, GSK, TRV | 13F-HR | 11 May 2020, 12:21 |
| Q4 2019 | 53 | $2,908,669,000 | +$241,687,530 | -$270,698,393 | -$29,010,863 | SHV, GSK, USB, UPS, TFC | 13F-HR | 11 Feb 2020, 17:05 |
| Q3 2019 | 47 | $2,801,208,000 | +$200,283,167 | -$311,771,300 | -$111,488,133 | SHV, UPS, GSK, USB, KR | 13F-HR | 12 Nov 2019, 09:32 |
| Q2 2019 | 62 | $2,864,440,000 | +$131,297,367 | -$292,952,060 | -$161,654,693 | SHV, EBAY, USB, GSK, AXP | 13F-HR | 05 Aug 2019, 12:48 |
| Q1 2019 | 60 | $2,963,137,000 | +$246,942,032 | -$323,449,627 | -$76,507,595 | SHV, GSK, UPS, XOM, EBAY | 13F-HR | 07 May 2019, 16:48 |
| Q4 2018 | 65 | $2,772,932,000 | +$292,437,455 | -$257,609,458 | +$34,827,997 | SHV, VZ, GSK, USB, EXC | 13F-HR | 12 Feb 2019, 19:34 |
| Q3 2018 | 61 | $3,098,887,000 | +$234,615,469 | -$340,591,832 | -$105,976,363 | SHV, XOM, GSK, TGT, AXP | 13F-HR | 05 Nov 2018, 16:49 |
| Q2 2018 | 56 | $3,076,756,000 | +$157,588,650 | -$145,269,923 | +$12,318,727 | SHV, EXC, XOM, GSK, AXP | 13F-HR | 03 Aug 2018, 10:25 |
| Q1 2018 | 57 | $3,014,158,000 | +$484,669,770 | -$348,570,574 | +$136,099,196 | SHV, GSK, EXC, XOM, USB | 13F-HR | 07 May 2018, 12:25 |
| Q4 2017 | 58 | $3,002,199,000 | +$103,892,904 | -$212,186,704 | -$108,293,800 | EXC, EBAY, AXP, TGT, WFC | 13F-HR | 12 Feb 2018, 16:08 |
| Q3 2017 | 53 | $2,898,373,000 | +$83,349,220 | -$194,092,769 | -$110,743,549 | EBAY, WMT, EXC, AXP, PNC | 13F-HR | 09 Nov 2017, 20:22 |
| Q2 2017 | 46 | $2,926,472,000 | +$93,949,525 | -$299,136,227 | -$205,186,702 | WMT, EXC, EBAY, MDT, AXP | 13F-HR | 04 Aug 2017, 12:28 |
| Q1 2017 | 40 | $3,071,150,000 | +$242,757,532 | -$353,662,081 | -$110,904,549 | EBAY, EXC, WMT, XOM, GSK | 13F-HR | 09 May 2017, 16:51 |
| Q4 2016 | 42 | $3,108,541,000 | $0 | $0 | $0 | WMT, EXC, PEP, XOM, EBAY | 13F-HR | 02 Feb 2017, 07:55 |